Viewing Study NCT02381535


Ignite Creation Date: 2025-12-24 @ 10:10 PM
Ignite Modification Date: 2026-02-18 @ 8:37 AM
Study NCT ID: NCT02381535
Status: COMPLETED
Last Update Posted: 2025-02-11
First Post: 2015-03-05
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Onalespib in Treating Patients With Locoregionally Advanced Squamous Cell Carcinoma of the Head and Neck Receiving Radiation Therapy and Cisplatin
Sponsor: National Cancer Institute (NCI)
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module